Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer

Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique

(2014) Yanghuan Ye et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals

(2014) Lisha Wei et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

In vitro and in vivo models for the study of oral delivery of nanoparticles

(2013) Jennifer M. Gamboa et al.   ADVANCED DRUG DELIVERY REVIEWS

Bexarotene nanocrystal—Oral and parenteral formulation development, characterization and pharmacokinetic evaluation

(2013) Lijiang Chen et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo

(2012) W. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs

(2012) Chunbai He et al.   BIOMATERIALS

Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations

(2012) Xiang-Hua Zhang et al.   CANCER LETTERS

In vitro antitumor activity of silybin nanosuspension in PC-3 cells

(2011) Dandan Zheng et al.   CANCER LETTERS

A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors

(2011) Shakun M. Malik et al.   Clinical Lung Cancer

Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations

(2011) Neha Mehta et al.   Clinical Lymphoma Myeloma & Leukemia

Twenty years of drug nanocrystals: Where are we, and where do we go?

(2011) R.H. Müller et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Formation, characterization, and fate of inhaled drug nanoparticles

(2010) Jian Zhang et al.   ADVANCED DRUG DELIVERY REVIEWS

Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension

(2010) Yancai Wang et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Potentials of new nanocarriers for dermal and transdermal drug delivery

(2010) Reinhard H.H. Neubert   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells

(2010) Venkateswaran Subramaniam et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model

(2010) Wilson H. Roa et al.   JOURNAL OF CONTROLLED RELEASE

Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B

(2010) Swarnali Das et al.   Nanomedicine-Nanotechnology Biology and Medicine

Bexarotene: a promising anticancer agent

(2009) Liyan Qu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Nanotechnology and the transdermal routeA state of the art review and critical appraisal

(2009) Gregor Cevc et al.   JOURNAL OF CONTROLLED RELEASE

Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo

(2008) Hongbo Wang et al.   CANCER LETTERS